CWM
TCON

Cornerstone Wealth Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Cornerstone Wealth Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-39
Closed -$3M – 1581
2018
Q2 		$3M Buy
+39
New +$20.7K 0.03% 422

Other funds holding TCON

PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cornerstone Wealth Management's TCON Position: Q3 2018 in Review

Cornerstone Wealth Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2018, closing a stake of 39 shares — an estimated $3M sold.

Cornerstone Wealth Management first reported a position in TCON in Q2 2018 and held it in 1 quarter. The position peaked at $3M in Q2 2018. 37 funds tracked by Wall St. Rank hold TCON as of Q3 2018.

  • Cornerstone Wealth Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Cornerstone Wealth Management sold 39 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $3M.
  • Cornerstone Wealth Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Cornerstone Wealth Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $3M in Q2 2018.
  • 37 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Cornerstone Wealth Management's 13F filing for Q3 2018, filed 19 Oct 2018.